Showing results (2101-2110 of 3,020) with videos related to

Sort By:
Pageof 302
International Journal of Cardiology|August 27, 2013
Meeting the challenge: the evolving global landscape of adult congenital heart diseaseAleksander Kempny, Rodrigo Fernández-Jiménez, Oktay Tutarel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myelomaK Jack Ishak, J Jaime Caro, Mark T Drayson, et al.
BJU International|December 9, 2015
Dynamic sentinel lymph node biopsy for penile cancer: a comparison between 1- and 2-day protocolsPanagiotis Dimopoulos, Panagiotis Christopoulos, Sam Shilito, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2018
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myelomaMeletios A Dimopoulos, Sebastian Grosicki, Wiesław W Jędrzejczak, et al.
Translational Vision Science & Technology|November 20, 2023
Safety and Efficacy of Adeno-Associated Viral Gene Therapy in Patients With Retinal Degeneration: A Systematic Review and Meta-AnalysisMohamad Sobh, Pamela S Lagali, Maryam Ghiasi, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Molecular Profiling and Treatment Outcomes in Uterine Serous Carcinoma: Prognostic Role of Estrogen Receptor ExpressionAnna Svarna, Michalis Liontos, Kallirroi Goula, et al.
International Journal of Hematology|August 8, 2019
Outcomes for Asian patients with multiple myeloma receiving once- or twice-weekly carfilzomib-based therapy: a subgroup analysis of the randomized phase 3 ENDEAVOR and A.R.R.O.W. TrialsMeletios A Dimopoulos, Philippe Moreau, Shinsuke Iida, et al.
Haematologica|February 8, 2006
Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myelomaMeletios A Dimopoulos, Athanasios Anagnostopoulos, Evangelos Terpos, et al.
Blood Cancer Journal|March 16, 2025
Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcomeKonstantinos Soureas, Panagiotis Malandrakis, Maria-Alexandra Papadimitriou, et al.
Molecular Biology Reports|May 11, 2013
MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European populationFlora Zagouri, Theodoros N Sergentanis, Maria Gazouli, et al.
Pageof 302